Search bioRxiv⌕ Search

Biology subjects

Meissner, K.

Publications and source records attributed to Meissner, K..

6 recordsLinked to original sources

Prefrontal cortex resting-state connectivity is moderated by hunger expectations induced by a placebo intervention in healthy female participants.

Placebo effects, in which a patient's symptoms and subjective well-being improve in response to an inactive treatment, medication, or intervention (a placebo), are well known in clinical research. Basic research in human cognition and neuroscience has shown that these effects are linked to prognostic expectations of effectiveness and to recruitment of prefrontal cortex regions, including the medial (mPFC), ventromedial (vmPFC), and dorsolateral prefrontal cortex (dlPFC). Here, we examined how the intrinsic functional connectivity of these three brain regions at rest, in the absence of any explicit task, was affected by internal beliefs such as placebo-induced hunger expectations. We conducted a seed-based resting-state functional connectivity analysis in 60 healthy female participants who underwent a placebo intervention targeting their hunger. In line with previously published results, the intervention induced hunger expectations and biased hunger sensations. Importantly, these effects were underpinned by attenuated functional connectivity between the mPFC and the angular gyrus within the default mode network the more participants expected the placebo to decrease their hunger. Hunger-increasing expectations attenuated connectivity between the vmPFC and the dm/dlPFC within the frontoparietal network and increased connectivity between the dlPFC and the thalamus. These results suggest that placebo-induced hunger expectations shift the way the prefrontal cortex connects to other brain regions associated with valuation, cognitive control, and interoception. This evidence sheds light on how the brain may translate incoming sensory information into biased sensations under placebo conditions and improves our understanding of the neural and psychological factors that influence a person's response to a placebo.

neuroscience↗

Red blood cell-tumour cell interactions promote tumour cell progression

One critical step in the metastatic cascade is the survival of circulating tumour cells (CTCs) within the bloodstream. While numerous interactions between CTCs and various hematopoietic cells have been described, the role of red blood cells (RBCs) in this process remains underexplored. This study investigates the interactions between tumour cells and RBCs from breast and lung cancer patients, revealing significant phenotypic and functional changes in the tumour cells, unlike when the contact is with RBCs from healthy donors. In vitro co-culture of cancer cell lines with RBCs from metastatic cancer patients resulted in increased tumour cell attachment accompanied by morphological changes. Additionally, RBCs-primed tumour cells showed increased adhesion and disruption of the endothelial barrier in vitro and increased invasiveness both in vitro and in vivo. Transcriptomic analysis showed that RBCs from metastatic breast cancer patients induce significant gene expression changes, notably upregulating PAK4, which enhances migration and epithelial-mesenchymal transition. PAK4 inhibition reduced these effects. Proteomic studies revealed substantial remodelling, including actin-related changes and the accumulation of VASP at cell edges, promoting directional migration. Clinically, higher RBC distribution width (RDW) in metastatic breast cancer patients is associated with increased CTC counts and worse outcome. This study highlights the previously unrecognized role of RBCs in promoting metastatic behaviours in cancer cells and suggests potential therapeutic targets, such as PAK4, to counteract these effects. Further exploration of RBCs-tumour cell interactions could provide new insights into metastatic mechanisms and improve cancer prognosis and treatment strategies. Key PointsO_LIThis study reveals the previously unknown role of RBCs in enhancing tumour cell invasiveness and metastatic potential. C_LIO_LITumour cells undergo significant phenotypic and functional changes after contact with RBCs from cancer patients. C_LI

cancer biology↗

Taste matters: Mapping expectancy-based appetitive placebo effects onto the brain

Expectancies, which are higher order prognostic beliefs, can have powerful effects on experiences, behavior and brain. However, it is unknown where, how, and when, in the brain, prognostic beliefs influence appetitive interoceptive experiences and related economic behavior. This study combined a placebo intervention on hunger with computational modelling and functional magnetic resonance imaging of value-based decision-making. The results show that prognostic beliefs about hunger shape hunger experiences, how much participants value food and food-value encoding in the prefrontal cortex. Computational modelling further revealed that these placebo effects were underpinned by how much and when during the decision process taste and health information are integrated into the accumulation of evidence toward a food choice. The drift weights of both sources of information further moderated ventromedial and dorsolateral prefrontal cortex interactions during choice formation. These findings provide novel insights into the neurocognitive mechanisms that translate higher order prognostic beliefs into non-aversive interoceptive sensitivity and shape decision-making.

neuroscience↗

Jetlag Expectations, not Circadian Parameters, Predict Jetlag Symptom Severity in Travelers

After a flight across multiple time zones, most people show a transient state of circadian misalignment causing temporary malaise known as jetlag disorder. The severity of the elicited symptoms is postulated to depend mostly on circadian factors such as the number of time zones crossed and the direction of travel. Here, we examined the influence of prior expectation on symptom severity, compared to said "classic" determinants, in order to gauge potential psychosocial effects in jetlag disorder. To this end, we monitored jetlag symptoms in travel-inexperienced individuals (n=90, 18-37y) via detailed questionnaires twice daily for one week before and after flights crossing >3 time zones. We found pronounced differences in individual symptom load that could be grouped into 4 basic symptom trajectories. Both traditional and newly devised metrics of jetlag symptom intensity and duration (accounting for individual symptom trajectories) recapitulated previous results of jetlag prevalence at about 50-60% as well as general symptom dynamics. Surprisingly, however, regression models showed very low predictive power for any of the jetlag outcomes. The classic circadian determinants, including number of time zones crossed and direction of travel, exhibited little to no link with jetlag symptom intensity and duration. Only expectation emerged as a parameter with systematic, albeit small, predictive value. These results suggest expectation as a relevant factor in jetlag experience - hinting at potential placebo effects and new treatment options. Our findings also caution against jetlag recommendations based on circadian principles but insufficient evidence linking circadian re-synchronization dynamics with ensuing symptom intensity and duration. Significance StatementJetlag disorder afflicts millions of travelers each year - a nuisance on holiday trips but also a danger in safety and performance-critical operations. For effective prevention and treatment, it is critical to understand what influences jetlag severity, i.e. jetlag symptom intensity and duration. In contrast to what guidelines state, in our study, we did not find that symptom severity could be explained by the number of time zones crossed or travel direction. Rather, travelers expectations about how long and strongly they will suffer from jetlag symptoms was the only factor systematically predicting jetlag severity. If this holds true not only for subjective but also objective symptoms, we need to revisit assumptions about how circadian desynchronization relates to experienced jetlag symptoms.

neuroscience↗

Deep learning and computer vision will transform entomology

ABSTRACTMost animal species on Earth are insects, and recent reports suggest that their abundance is in drastic decline. Although these reports come from a wide range of insect taxa and regions, the evidence to assess the extent of the phenomenon is still sparse. Insect populations are challenging to study and most monitoring methods are labour intensive and inefficient. Advances in computer vision and deep learning provide potential new solutions to this global challenge. Cameras and other sensors that can effectively, continuously, and non-invasively perform entomological observations throughout diurnal and seasonal cycles. The physical appearance of specimens can also be captured by automated imaging in the lab. When trained on these data, deep learning models can provide estimates of insect abundance, biomass, and diversity. Further, deep learning models can quantify variation in phenotypic traits, behaviour, and interactions. Here, we connect recent developments in deep learning and computer vision to the urgent demand for more cost-efficient monitoring of insects and other invertebrates. We present examples of sensor-based monitoring of insects. We show how deep learning tools can be applied to the big data outputs to derive ecological information and discuss the challenges that lie ahead for the implementation of such solutions in entomology. We identify four focal areas, which will facilitate this transformation: 1) Validation of image-based taxonomic identification, 2) generation of sufficient training data, 3) development of public, curated reference databases, and 4) solutions to integrate deep learning and molecular tools.Significance statement Insect populations are challenging to study, but computer vision and deep learning provide opportunities for continuous and non-invasive monitoring of biodiversity around the clock and over entire seasons. These tools can also facilitate the processing of samples in a laboratory setting. Automated imaging in particular can provide an effective way of identifying and counting specimens to measure abundance. We present examples of sensors and devices of relevance to entomology and show how deep learning tools can convert the big data streams into ecological information. We discuss the challenges that lie ahead and identify four focal areas to make deep learning and computer vision game changers for entomology.Competing Interest StatementThe authors have declared no competing interest.GlossaryBin pickingan industrial term for robots that pick up one of many objects randomly placed in a container.Convolutional Neural Network (CNN)a deep learning algorithm in the family of neural networks with serval different layers commonly applied for image recognition and classification. A CNN can be trained to recognize various objects and patterns in an image. There are four main different operations in a CNN: convolution, activation functions, sub sampling, and fully connected layer. During training the learnable parameters of each convolutional and fully connected layer are adjusted so the CNN is able to recognize different patterns of the training data and used for final image classification.Data augmentationa technique that can be used to artificially expand the size of a training dataset by creating modified images with objects of interest for classification.Machine learninga subset of artificial intelligence associated with creating algorithms that can change themselves without human intervention to get the desired result – by feeding themselves through structured data.Deep learninga subset of machine learning where algorithms are created and function similarly to machine learning, but where there are many levels of these algorithms, each providing a different interpretation of the data it conveys.DNA barcodingIdentification of a species using a short, standardised gene fragment.Initializationdescription of an object to be tracked.Training dataclassified images (e.g. images of known species identified by experts) that are recorded to train a deep learning model.Precisionthe number of true positives divided by the sum of true positives and false positivesRecallalso called the true positive rate, is the number of true positives divided by the sum of true positives and false negatives.Classification accuracythe sum of true positives and true negatives divided by the total number of specimens.View Full Text

ecology↗

Molecular classification of the placebo effect in nausea

Numerous studies have shown that the mere expectation improvement can alleviate symptoms in various conditions. These placebo effects often include reliable changes in central and peripheral organ systems. Here, we tested for the first time whether placebo effects can be monitored and predicted by plasma proteins. In a randomized controlled design, 90 healthy participants were exposed to a 20-min vection stimulus on two separate days and were randomly allocated to placebo treatment or no treatment on the second day. Significant placebo effects on nausea, motion sickness, and gastric activity could be verified. Using state-of-the-art proteomics, 74 differentially regulated proteins were identified in placebo-treated participants as compared to no-treatment controls. Gene ontology (GO) enrichment analyses of these proteins revealed acute-phase proteins as well as microinflammatory proteins to be reliable plasma correlates of the placebo effect. Regression analyses showed that day-adjusted scores of nausea indices in the placebo group were predictable by the identified GO protein signatures. We next identified specific plasma proteins, for which a significant amount of variance could be explained by the experimental factors sex, group, nausea, or their interactions. GO enrichment analyses of these proteins identified grooming behavior as a prominent hit, based on neurexin-1 (NRXN1) and contactin-associated protein-like 4 (CNTNAP4). Finally, Receiver Operator Characteristics (ROC) allowed to identify specific plasma proteins differentiating placebo responders from non-responders. These comprised immunoglobulins (IGHM, IGKV1D-16, IGHV3-23, IGHG1) and MASP2, related to regulation of complement activation, as well as proteins involved in oxidation reduction processes (QSOX1, CP TXN). This proof-of-concept study indicates that plasma proteomics are a promising tool to identify molecular correlates and predictors of the placebo effect in humans.

neuroscience↗